Search research articles
Contact Us
Filters
Showing results (841-850 of 1,300) with videos related to
Page
of 130
Sort By:
Technology in Cancer Research & Treatment
|
October 23, 2014
Quantitative Analysis Tools and Digital Phantoms for Deformable Image Registration Quality Assurance
Haksoo Kim, Samuel B Park, James I Monroe, et al.
Anticancer Research
|
August 15, 2001
Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer
L M Tseng, C Y Hsu, H C Wang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
May 1, 2001
The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus
Y J Lee, F S Lo, S G Shu, et al.
Oncotarget
|
November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF<sup>V600E</sup>
Zeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.
Plos One
|
July 9, 2021
Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay
Anders H Berg, Mahtab Tavasoli, Agnes S Lo, et al.
Expert Review of Anticancer Therapy
|
May 18, 2010
Management of metastatic spinal cord compression
Kevin Shiue, Arjun Sahgal, Edward Chow, et al.
International Journal of Systematic and Evolutionary Microbiology
|
June 6, 2020
<i>Parapseudoflavitalea muciniphila</i> gen. nov., sp. nov., a member of the family <i>Chitinophagaceae</i> isolated from a human peritoneal tumour and reclassification of <i>Pseudobacter ginsenosidimutans</i> as <i>Pseudoflavitalea ginsenosidimutans</i> comb. nov
Paul A Lawson, Nisha B Patel, Ahmed Mohammed, et al.
HIV Medicine
|
July 16, 2003
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study
C Torti, E Quiros-Roldan, L Scudeller, et al.
Molecular Cancer Therapeutics
|
September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine
James S Wilmott, Varsha Tembe, Julie R Howle, et al.
Virology
|
February 9, 2000
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia
Y J Guo, S Krauss, D A Senne, et al.
Page
of 130
Search research articles
Search
Showing results (841-850 of 1,300) with videos related to
Sort By:
Page
of 130
Technology in Cancer Research & Treatment
|
October 23, 2014
Quantitative Analysis Tools and Digital Phantoms for Deformable Image Registration Quality Assurance
Haksoo Kim, Samuel B Park, James I Monroe, et al.
Anticancer Research
|
August 15, 2001
Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancer
L M Tseng, C Y Hsu, H C Wang, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM
|
May 1, 2001
The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitus
Y J Lee, F S Lo, S G Shu, et al.
Oncotarget
|
November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF<sup>V600E</sup>
Zeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.
Plos One
|
July 9, 2021
Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assay
Anders H Berg, Mahtab Tavasoli, Agnes S Lo, et al.
Expert Review of Anticancer Therapy
|
May 18, 2010
Management of metastatic spinal cord compression
Kevin Shiue, Arjun Sahgal, Edward Chow, et al.
International Journal of Systematic and Evolutionary Microbiology
|
June 6, 2020
<i>Parapseudoflavitalea muciniphila</i> gen. nov., sp. nov., a member of the family <i>Chitinophagaceae</i> isolated from a human peritoneal tumour and reclassification of <i>Pseudobacter ginsenosidimutans</i> as <i>Pseudoflavitalea ginsenosidimutans</i> comb. nov
Paul A Lawson, Nisha B Patel, Ahmed Mohammed, et al.
HIV Medicine
|
July 16, 2003
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex Study
C Torti, E Quiros-Roldan, L Scudeller, et al.
Molecular Cancer Therapeutics
|
September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicine
James S Wilmott, Varsha Tembe, Julie R Howle, et al.
Virology
|
February 9, 2000
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia
Y J Guo, S Krauss, D A Senne, et al.
Page
of 130